Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
18.03. | PEUGEOT INVEST: Peugeot Invest successfully sold half of its stake in SPIE | ||
17.03. | SAINT-GOBAIN (COMPAGNIE DE): Reporting on share buyback transactions carried out between March 10 and March 14, 2025 | ||
17.03. | GBL: GBL - Transactions on GBL shares 17-03-2025 | ||
17.03. | HYBRID SOFTWARE GROUP PLC: Update on the share repurchase program | ||
17.03. | ADP: Aéroports de Paris S.A - February 2025 traffic figures | ||
17.03. | SCHNEIDER ELECTRIC SE: Weekly share buyback | ||
17.03. | PEUGEOT INVEST: Peugeot Invest launches the sale of half of its stake in SPIE | ||
17.03. | EURAZEO SE: Disclosure of transactions in own shares from March 10 to March 14, 2025 | ||
17.03. | VANDOR REAL ESTATE SOCIMI S.A.U.: VANDOR REAL ESTATE SOCIMI - Asset acquisition | ||
17.03. | BIOPHYTIS: Biophytis revolutionizes sarcopenia | ||
17.03. | JENSEN-GROUP: Share buyback - weekly update | ||
14.03. | Rebirth S.p.A.: VALUE OF ANNUAL PRODUCTION DOUBLED TO 4.5 MILLIONS EUROS | ||
14.03. | Euronext announces March 2025 quarterly review results of the MIB ESG® | ||
14.03. | VAN DE VELDE: acquisition of treasury shares | ||
14.03. | OPMOBILITY: Availability of the 2024 Universal Registration Document of OPmobility SE | ||
14.03. | SAFRAN: Statement about the number of shares composing the share capital and the number of voting rights as at February 28, 2025 | ||
14.03. | ADP: Aéroports de Paris SA - €1bn dual-tranche new bond issue | ||
14.03. | OCI N.V.: OCI Global Reports H2 2024 Results | ||
14.03. | INTERPARFUMS: Coach and Interparfums extend their partnership in the universe of fragrances until June 2031 | ||
13.03. | BE Semiconductor Industries N.V.: BE Semiconductor Industries N.V. Announces Transactions Under Share Repurchase Program | ||
13.03. | Euronext announces March 2025 quarterly review results of the CAC 40 ESG® | ||
13.03. | ALPES (COMPAGNIE): CDA - Sharholder Meeting report - March 13 | ||
13.03. | Euronext announces March 2025 annual review results of the ISEQ® Family | ||
13.03. | HYLORIS: Hyloris Announces Positive Study Results for Dofetilide IV | ||
13.03. | Euronext announces March 2025 quarterly review results of the CAC® Family |